{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T17:54:14Z","timestamp":1772214854513,"version":"3.50.1"},"reference-count":25,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.3892\/ol.2015.3338","type":"journal-article","created":{"date-parts":[[2015,6,8]],"date-time":"2015-06-08T08:30:33Z","timestamp":1433752233000},"page":"2223-2226","source":"Crossref","is-referenced-by-count":4,"title":["Thrombotic thrombocytopenic purpura following salvage chemotherapy with paclitaxel, ifosfamide and cisplatin in a patient with a refractory germ cell tumor: A case report and review of the literature"],"prefix":"10.3892","volume":"10","author":[{"given":"ARIFE","family":"ULAS","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KAMILE","family":"SILAY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SEMA","family":"AKINCI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MUHAMMED BULENT","family":"AKINCI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MEHMET ALI","family":"SENDUR","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DIDEM SENER","family":"DEDE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUNUS HALIL","family":"POLAT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BULENT","family":"YALCIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,6,8]]},"reference":[{"key":"key20180108100454_b1-ol-0-0-3338","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/archinte.1925.00120130092009","article-title":"An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries: An undescribed disease","volume":"36","author":"Moschowitz","year":"1925","journal-title":"Arch Intern Med"},{"key":"key20180108100454_b2-ol-0-0-3338","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-196603000-00003","article-title":"Thrombotic thrombocytopenic purpura: Report of 16 cases and review of the literature","volume":"45","author":"Amorosi","year":"1966","journal-title":"Medicine"},{"key":"key20180108100454_b3-ol-0-0-3338","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ajh.2830500203","article-title":"Increasing mortality from thrombotic thrombocytopenic purpura in the United States-analysis of national mortality data, 1968\u20131991","volume":"50","author":"T\u00f6r\u00f6k","year":"1995","journal-title":"Am J Hematol"},{"key":"key20180108100454_b4-ol-0-0-3338","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group","volume":"325","author":"Rock","year":"1991","journal-title":"N Engl J Med"},{"key":"key20180108100454_b5-ol-0-0-3338","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1046\/j.1523-1755.2001.060003831.x","article-title":"Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura","volume":"60","author":"Ruggenenti","year":"2001","journal-title":"Kidney Int"},{"key":"key20180108100454_b6-ol-0-0-3338","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-2007-994923","article-title":"Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura hemolytic uremic syndrome in the cancer patient","volume":"25","author":"Gordon","year":"1999","journal-title":"Semin Thromb Hemost"},{"key":"key20180108100454_b7-ol-0-0-3338","first-page":"271","volume-title":"Hemolytic-Uremic Syndrome and Thrombotic Thrombocytopenic Purpura (Kidney Disease S v. 10)","author":"Murgo","year":"1992"},{"key":"key20180108100454_b8-ol-0-0-3338","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1526-0968.2003.00127.x","article-title":"Drug-induced thrombotic thrombocytopenic purpura\/haemolytic uremic syndrome: A concise review","volume":"8","author":"Dlott","year":"2004","journal-title":"Ther Apher Dial"},{"key":"key20180108100454_b9-ol-0-0-3338","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1200\/JCO.1985.3.5.723","article-title":"Carcinoma-associated hemolytic-uremic syndrome: A complication of mitomycin C chemotherapy","volume":"3","author":"Cantrell","year":"1985","journal-title":"J Clin Oncol"},{"key":"key20180108100454_b10-ol-0-0-3338","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.clcc.2011.03.012","article-title":"Mitomycin-C-induced thrombotic thrombocytopenic purpura\/hemolytic uremic syndrome: Cumulative toxicity of an old drug in a new era","volume":"10","author":"ElGhazal","year":"2011","journal-title":"Clin Colorectal Cancer"},{"key":"key20180108100454_b11-ol-0-0-3338","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S1470-2045(07)70203-6","article-title":"Gemcitabine-associated thrombotic thrombocytopenic purpura","volume":"8","author":"Zupancic","year":"2008","journal-title":"Lancet Oncol"},{"key":"key20180108100454_b12-ol-0-0-3338","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00277-007-0429-9","article-title":"Development of thrombotic thrombocytopenic purpura after a single dose of gemcitabine","volume":"87","author":"De Smet","year":"2008","journal-title":"Ann Hematol"},{"key":"key20180108100454_b13-ol-0-0-3338","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/08860228909066955","article-title":"Hemolytic uremic syndrome following cisplatin, bleomycin, and vincristine chemotherapy: A report of a case and a review of the literature","volume":"11","author":"Gardner","year":"1989","journal-title":"Ren Fail"},{"key":"key20180108100454_b14-ol-0-0-3338","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1200\/JCO.2012.42.5082","article-title":"Oxaliplatin-induced thrombotic thrombocytopenic purpura: Case report and literature review","volume":"30","author":"Jiaxin","year":"2012","journal-title":"J Clin Oncol"},{"key":"key20180108100454_b15-ol-0-0-3338","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the propability of advers drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"key20180108100454_b16-ol-0-0-3338","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood-2008-02-078170","article-title":"Von Willebrand factor, ADAMST13 and thrombotic thrombocytopenic purpura","volume":"112","author":"Sadler","year":"2008","journal-title":"Blood"},{"key":"key20180108100454_b17-ol-0-0-3338","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1055\/s-2005-925474","article-title":"Drug-induced thrombotic microangiopathy","volume":"31","author":"Zakarija","year":"2005","journal-title":"Semin Thromb Hemost"},{"key":"key20180108100454_b18-ol-0-0-3338","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1097\/01.ASN.0000060805.04118.4C","article-title":"Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura","volume":"14","author":"Tsai","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"key20180108100454_b19-ol-0-0-3338","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000326801","article-title":"Thrombotic thrombocytopenic purpura and gemcitabine","volume":"4","author":"Kasi","year":"2011","journal-title":"Case Rep Oncol"},{"key":"key20180108100454_b20-ol-0-0-3338","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/1097-0142(19901101)66:9<1914::AID-CNCR2820660910>3.0.CO;2-G","article-title":"Chemotherapy-related hemolytic-uremic syndrome after the treatment of head and neck cancer. A case report","volume":"66","author":"Gradishar","year":"1999","journal-title":"Cancer"},{"key":"key20180108100454_b21-ol-0-0-3338","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s12032-009-9333-6","article-title":"Thrombotic microangiopathy following docetaxel and trastuzumab chemotherapy: A case report","volume":"27","author":"Siau","year":"2010","journal-title":"Med Oncol"},{"key":"key20180108100454_b22-ol-0-0-3338","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s12032-013-0568-x","article-title":"Thrombotic microangiopathy during docetaxel, trastuzumab, and carboplatin chemotherapy for early stage HER2+ breast cancer. A case report","volume":"30","author":"Iams","year":"2013","journal-title":"Med Oncol"},{"key":"key20180108100454_b23-ol-0-0-3338","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2165\/00002018-200124070-00002","article-title":"Drug-induced thrombotic microangiopathy: Incidence, prevention and management","volume":"24","author":"Pisoni","year":"2001","journal-title":"Drug Saf"},{"key":"key20180108100454_b24-ol-0-0-3338","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11239-012-0723-9","article-title":"Efficacy of rituximab in acute refractory or chronic relapsing non familial idiopathic thrombotic thrombocytopenic purpura: A systematic review with pooled data analysis","volume":"34","author":"Tun","year":"2012","journal-title":"J Thromb Thrombolysis"},{"key":"key20180108100454_b25-ol-0-0-3338","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.2169\/internalmedicine.52.9180","article-title":"Drug-induced thrombotic thrombocytopenic purpura successfully treated with recombinant human soluble thrombomodulin","volume":"52","author":"Nishijima","year":"2013","journal-title":"Intern Med"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2015.3338\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T07:18:58Z","timestamp":1515395938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2015.3338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,8]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,6,8]]},"published-print":{"date-parts":[[2015,10]]}},"alternative-id":["10.3892\/ol.2015.3338"],"URL":"https:\/\/doi.org\/10.3892\/ol.2015.3338","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,8]]}}}